> INTERFERONS have been reported to reduce the activity of hepatic cytochrome P450 -dependent ENZYMES in humans and animals. Caution should be exercised when BETAFERON i s administered in combination with medicinal products that have a narrow therapeutic index and are largely dependent on the hepatic cytochrome P450 system for clearance, e.g. anti -epileptics. Additional caution should be exercised with any co -medication wh ich has an effect on the haematopoietic  system. 
